Schedule H1 explained: Why did India tighten its prescription rules for high-alcohol medicines?

The government has brought high-alcohol-content oral medicines, like certain cough syrups and tonics, under Schedule H1, a stricter drug classification that already governs several other high-risk medicines in India.

Here's what Schedule H1 means, why it exists, which medicines fall under it, and what changes for patients and pharmacies.

What is Schedule H1?

Schedule H1 is a category under the Drugs Rules, 1945, made under the Drugs and Cosmetics Act, 1940, for medicines that cannot be sold over the counter and require a prescription from a Registered Medical Practitioner (RMP), according to the National TB Elimination Programme (NTEP), a Government of India public health resource.


Also read: Medicines with over 12% alcohol can no longer be sold without prescription: Govt

It sits above the regular Schedule H, which already covers over 500 prescription drugs, and comes with additional conditions. Chemists are required to maintain detailed sales records for every Schedule H1 medicine, beyond simply checking for a prescription.

Each pack also carries a red "Rx" symbol on the top left corner, along with a boxed warning label stating that the preparation is dangerous to take except on medical advice and cannot be sold without a doctor's prescription, per the NTEP resource, citing the original 2013 notification.

Why was it introduced?

Schedule H1 was first introduced through a Gazette notification in August 2013, to tighten control over medicines with a higher potential for misuse than ordinary Schedule H drugs, such as certain antibiotics, habit-forming drugs and anti-TB medicines, according to a Press Information Bureau (PIB) release by the Ministry of Health and Family Welfare.

According to the Ministry, the concern was that such drugs, if freely available without medical supervision, could be misused, contribute to antimicrobial resistance, or lead to dependence. Requiring pharmacies to log every sale was intended to create a traceable dispensing record for these medicines.

The list has since been expanded periodically. The latest addition came through a notification dated July 8, 2026. As per a Ministry press release from July 10, 2026, this amendment was prompted by concerns over certain alcohol-based tonics and tinctures, some containing as much as 80-90% ethyl alcohol, that had earlier been exempt from licensing and were reportedly being misused for intoxication. The Ministry noted that references flagging this concern were also received from certain state governments.

The Drugs Technical Advisory Board (DTAB) and the Drugs Consultative Committee (DCC) had earlier examined proposals to move high-alcohol preparations out of the Schedule K exemption and into Schedule H1, according to a report by ET Bureau. A draft notification proposing the 12% v/v, 30 mL threshold was circulated for public comment in October 2025, before the rule was finalised this July.

Which medicines come under it now?

Originally, Schedule H1 covered certain third- and fourth-generation antibiotics, select habit-forming drugs, and anti-TB medicines like ethambutol, isoniazid, levofloxacin and rifampicin, per the NTEP resource. Pregabalin was among the more recent additions before this latest change.

As of the July 2026 amendment, all oral formulations containing more than 12% alcohol by volume, packed and sold in bottles larger than 30 mL, have been added as entry 52 under Schedule H1. Per the Ministry's release, these formulations have also simultaneously lost an exemption they earlier held under a separate rule (Schedule K), meaning manufacturers will now additionally require a drug licence to sell them, on top of the prescription requirement.

Under Schedule K of the Drugs Rules, 1945, certain formulations, including tinctures of cardamom, ginger and other aromatic preparations, had long been exempt from the licensing requirements otherwise mandated by the Drugs and Cosmetics Act, 1940, per the ET Bureau report. Some of these products contain ethyl alcohol concentrations as high as 80-90% v/v.

An official told ET Bureau that manufacturers of such products will now need to obtain proper licences under the 1940 Act, and that the products have been moved into Schedule H1, the category reserved for medicines that can only be sold against an RMP's prescription, with strict record-keeping obligations for pharmacies.

Can you buy these medicines without a prescription?

Chemists are required to follow a specific process for every Schedule H1 sale: maintain a separate register noting the prescriber's name and address, the patient's name, the drug name and the quantity supplied, and retain this record for at least three years so it is available for inspection by drug regulators.

Also read: What is CAR T-cell therapy? The 'living drug' that helped Sam Neill become cancer free

For the newly-included alcohol-based formulations specifically, the Ministry's release states that the aim is to ensure these medicines move only through the regulated pharmaceutical supply chain, reducing the possibility of diversion and misuse, while keeping them available for legitimate therapeutic use. Officials cited by ET Bureau echoed this, saying the change should curb diversion and misuse while keeping the products available for genuine therapeutic purposes through pharmacies operating under the tighter Schedule H1 controls.

What if the rules are broken?

Selling, stocking or dispensing a Schedule H1 drug without following these conditions is a criminal offence under the Drugs and Cosmetics Act, 1940. Contraventions can attract imprisonment along with fines, and courts can impose harsher penalties for repeat or wilful violations, per the provisions of the Act.

Enforcement is carried out by state Drug Inspectors, who are empowered to conduct inspections, seize non-compliant stock, and initiate prosecution against pharmacies that do not follow the prescription or record-keeping requirements. The licensing authority can also suspend or cancel a pharmacy's retail or wholesale drug licence for such violations.

For patients, the classification does not restrict access to medicines that are genuinely needed. It means a valid prescription and proper documentation are now required for a wider set of medicines, including certain high-alcohol oral formulations that were previously more freely available.